Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : ET and the Rest -- Ignore unavailable to you. Want to Upgrade?

To: Curtis E. Bemis who wrote (3597)	7/9/2001 4:27:20 PM
From: BWAC	Respond to of 5459

<You know, these guys just don't get it. Customer confidence begins with the overall health and longevity of the company, aka. shareholder value> Sure they don't get that. But they do get options and I guess that is about all that matters to them. <like to have a sincere discussion about "poison pills" > Good luck. Apparently we can barely get in the front door. So? Possibly find out when the Board meets again and have a group letter delivered to them on that day requiring signatures of each director upon receipt? Beats me? Or drop by the NY coffee and donut chimp trading megawastehouse and hold a big sign up saying "Where is the shareholder value. Speak Cotsakos Speak"? Any disgruntled ET employees around? Any lawyers around looking to make a name for yourself? Basically it appears no one cares. Everybody but us few would just rather sell and go away, than collectively do something to force management out or into focus on shareholder value. Like we calculated before, obviously customers won't even hold 100 shares or $585 of ET stock. Or else there would be none available for sale. This one item should tell Cotsakos and management how poor of a job they are doing.

To: Curtis E. Bemis who wrote (3597)	7/10/2001 10:19:56 AM
From: BWAC	Read Replies (1) \| Respond to of 5459

Please let this go to a jury trial. Please. Oh please. "Blodget's bad news July 10, 2001 12:00 AM ET by Kent German From the July 2001 issue of UPSIDE magazine. Things are getting a little hairy for Merrill Lynch's (MER) Henry Blodget. Just two years ago, this braggart of an analyst could send a tech stock soaring just by opening his mouth; now, he is fighting off a new kind of threat that is circling ever closer. Claiming he was misled by two of Blodget's stock picks, Infospace (INSP) and JDS Uniphase (JDSU), New York doctor Debases Kanjilal filed a $10 million lawsuit against the boy wonder and Merrill Lynch last February......................" upside.com